Dexpanthenol and Keppra drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dexpanthenol (pantothenic acid (vitamin b5)) and Keppra (levetiracetam). Common drug interactions include constipation among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Dexpanthenol and Keppra. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Dexpanthenol?
Dexpanthenol has active ingredients of pantothenic acid (vitamin b5). eHealthMe is studying from 1,623 Dexpanthenol users. Check the latest studies of Dexpanthenol.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
18 people who take Dexpanthenol and Keppra together, and have interactions are studied.

What are the common drug interactions of Dexpanthenol and Keppra, by gender? *:
female:
- Constipation
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Anxiety
- Diplopia (double vision)
- Nausea (feeling of having an urge to vomit)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Skin hyperpigmentation (disorders affect the colour of your skin)
male:
- Fatigue (feeling of tiredness)
- Vomiting
- Cholecystitis (infection of gallbladder)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Evans syndrome (autoimmune disorder in which the body makes antibodies that destroy the red blood cells, platelets)
- Fall
- Gait disturbance
- Gastrointestinal hypermotility (over activity of the intestinal tract)
- Haemolytic anaemia (anaemia due to haemolysis)
What are the common drug interactions of Dexpanthenol and Keppra, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Fatigue (feeling of tiredness)
- Thrombocytopenia (decrease of platelets in blood)
- Abdominal discomfort
- Abdominal pain upper
- Abscess limb (limb infection)
- Blood triglycerides increased
- Blood urine present
- Bone marrow disorder
- Cholecystitis (infection of gallbladder)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
50-59:
- Disturbance in attention
- Headache (pain in head)
- Metastases to meninges (cancer spreads to meninges)
- Neutropenia (an abnormally low number of neutrophils)
- Optic nerve disorder (disease of optic nerve)
- Overdose
- Pneumonia
- Pulmonary embolism (blockage of the main artery of the lung)
- Venous thrombosis limb (blood clot that forms in a vein in the limb)
60+:
- Aspartate aminotransferase increased
- General physical health deterioration (weak health status)
- Gamma-glutamyltransferase increased
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Respiratory syncytial virus infection (viral disease of respiratory system)
- Blood alkaline phosphatase increased
- Chest pain
- Erythema (redness of the skin)
- Malignant neoplasm progression (cancer tumour came back)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
What are the existing conditions these people have? *
- High Blood Pressure: 6 people, 33.33%
- Multiple Myeloma (cancer of the plasma cells): 5 people, 27.78%
- Nausea (feeling of having an urge to vomit): 4 people, 22.22%
- Bone Pain: 4 people, 22.22%
- Pain: 4 people, 22.22%
- Stress And Anxiety: 4 people, 22.22%
- High Blood Cholesterol: 3 people, 16.67%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 16.67%
- Dry Skin: 3 people, 16.67%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Dexpanthenol and Keppra?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Dexpanthenol (1,623 reports)
- Keppra (73,504 reports)
Browse all drug interactions of Dexpanthenol and Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dexpanthenol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dexpanthenol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keppra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on pantothenic acid (vitamin b5) and levetiracetam (the active ingredients of Dexpanthenol and Keppra, respectively), and Dexpanthenol and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Triazolam cause Spinal Compression Fracture? - 5 seconds ago
- Could Enoxaparin Sodium cause Drug Toxicity? - 10 seconds ago
- Could Modafinil cause Breast Lump? - 15 seconds ago
- Drug interactions of Chloroquine Phosphate and Arava - 19 seconds ago
- Could Taxol cause Diabetes Mellitus Non-Insulin-Dependent? - 44 seconds ago
- Could Taxol cause Type 2 Diabetes? - 44 seconds ago
- Could Imiquimod cause Herpes Zoster? - 52 seconds ago
- Could Indocin cause Nosebleed? - a minute ago
- Trandolapril vs. Verapamil Hcl, side effect and effectiveness comparison - a minute ago
- Could Lipofen cause Cystitis Aggravated? - a minute ago